Solventum (SOLV) Expected to Announce Earnings on Thursday

Solventum (NYSE:SOLVGet Free Report) will likely be announcing its earnings results after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of $1.31 per share and revenue of $2.05 billion for the quarter. Investors interested in participating in the company’s conference call can do so using this link.

Solventum Price Performance

Shares of Solventum stock opened at $73.97 on Thursday. The company has a current ratio of 1.15, a quick ratio of 0.83 and a debt-to-equity ratio of 2.45. The company’s 50-day moving average price is $70.98 and its two-hundred day moving average price is $68.91. Solventum has a 52 week low of $47.16 and a 52 week high of $96.05.

Wall Street Analyst Weigh In

Several equities research analysts have commented on SOLV shares. Mizuho assumed coverage on shares of Solventum in a research report on Wednesday, December 4th. They issued a “neutral” rating and a $70.00 price target on the stock. Piper Sandler lifted their target price on Solventum from $71.00 to $75.00 and gave the company a “neutral” rating in a research note on Friday, November 8th. Finally, Morgan Stanley raised their price objective on shares of Solventum from $60.00 to $73.00 and gave the company an “equal weight” rating in a research report on Monday, November 11th. One analyst has rated the stock with a sell rating, nine have given a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $68.29.

Get Our Latest Report on Solventum

Solventum Company Profile

(Get Free Report)

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration.

Featured Stories

Receive News & Ratings for Solventum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Solventum and related companies with MarketBeat.com's FREE daily email newsletter.